You are here

  • Home
  • Archive
  • Volume 68, Issue 8
  • Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis

Article info

Article menu
Download PDFPDF
Letter
Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis

Authors

  1. Dr V Dolžan, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia, vita.dolzan{at}mf.uni-lj.si
View Full Text

Citation

Grabar PB, Rozman B, Logar D, et al
Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis
Annals of the Rheumatic Diseases 2009;68:1367-1368.

Publication history

  • Accepted October 12, 2008
  • First published July 15, 2009.
Online issue publication 
March 09, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 BMJ Publishing Group and European League Against Rheumatism